Lincoln Pharmaceuticals Ltd

Know More
NSEBSE

685.40-2.35 (-0.34%)

03:49 PM,29th Feb 2024

683.90-3.10 (-0.45%)

04:01 PM,29th Feb 2024

BSE : 531633

NSE : LINCOLN

Sector : Health care

ISIN Code : INE405C01035

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 29 2024 | 04:01 PM IST

Market Cap (₹ Cr)

1372

Turnover (₹ Cr)

0.68

Volume (Shares)

98894

Face Value

10

52-WK High

755.15

52-WK High Date

26 Feb 2024

52-WK Low

319.25

52-WK Low Date

14 Mar 2023

All Time High

755.15

All Time High Date

26 Feb 2024

All Time Low

85.05

All Time Low Date

19 Mar 2020

Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited promoted by Mahendra G Patel Rajnikant G Patel and Hasmukhbhai I Patel as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda Gujarat for manufacturing tablets capsules liquid and powder syrups and ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district) Gujarat to manufacture small volume parenterals like dry powder injectables liquid vial liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 2021-22 Lincoln Parenteral Limited (Transferor Company) an erstwhile subsidiary merged with Lincoln Pharmaceuticals Limited (the Transferee Company) through the Scheme of Amalgamation and consequent to this the Transferor Company ceases to be the subsidiary of the Company. The Company acquired a plant in Mehsana Gujarat to launch Cephalosporin products in 2022.

Lincoln Pharmaceuticals Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1372

EPS - TTM (₹) [S]

43.57

P/E Ratio (X) [S]

2.51

Face Value (₹) 10
Latest Dividend (%)15.00
Latest Dividend Date 15 Sep 2023
Dividend Yield (%) 0.22
Book Value Share (₹) [S]272.59
P/B Ratio (₹) [S]2.51
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Motilal Oswal S&P BSE Healthcare ETF 0.01 106 0.07

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

655.10

691.45

Week Low/High

655.10

755.00

Month Low/High

620.00

755.00

Year Low/High

319.25

755.00

All time Low/High

8.05

755.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week0.81%0.94%-0.90-1.06%
1 Month5.20%5.27%0.781.13%
3 Month3.21%3.47%8.379.39%
6 Month34.83%34.89%11.4113.65%
1 Year109.03%108.30%22.9627.04%
3 Year203.61%203.95%47.6651.30%

Company Info

Company Information

Chairman (Non-Executive) : Kishorbhai M Shah

Managing Director : Mahendra G Patel

Whole-time Director : Hasmukhbhai I Patel

Independent Director : Pirabhai R Suthar

Whole-time Director : Munjal Mahendrabhai Patel

Whole-time Director : Aashish R Patel

Independent Director : Meha Patel

Independent Director : Saurin J Parikh

Director : Rajnikant G Patel

Whole-time Director : Anand Arvindbhai Patel

Company Sec. & Compli. Officer : Trusha Shah

Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000

Email:info@lincolnpharma.com

URL:http://www.lincolnpharma.com